top of page
Search

Salesforce (CRM)

  • Writer: Abacus Research
    Abacus Research
  • Oct 31, 2024
  • 1 min read

Salesforce is another potential convert to ‘AI beneficiary’, plus there are reasons to be positive on continued margin expansion.

  • The business has the potential to see both better revenue growth as well as expanding operating margins with a share price that is discounting neither.

  • If CRM can apply AgentForce to its own sales process, and there is a high ROI, then street ests look conservative to us.


Potential Upside:     $375 (+25%)

Sensible Downside: $270 (-10%)


 
 
 

Recent Posts

See All
Brookfield (BN):

We initially wrote up BN in Jan 2024, it has increased 70%, so why mention it again? Firstly, we think the fundamentals are as good now as they were 2 yrs ago, with a >15% IRR on offer. BN is not a we

 
 
 
Figure (FIGR)

We believe Figure is highly disruptive. If tokenisation of real-world assets is a theme for the next decade, FIGR could be at the centre of it. Figure has found a real-world use for blockchain, provin

 
 
 

Comments

bottom of page